Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunostimulation. Clinical and experimental perspectives.

J Drews

    Klinische Wochenschrift
    |March 15, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Immunostimulating drugs, including microbial agents, synthetic compounds, and lymphokines, offer diverse approaches to enhancing immune responses. While challenges in standardization and dosage exist, these agents show promise for treating infections and cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sensing glucose concentrations at GHz frequencies with a fully embedded Biomicro-electromechanical system (BioMEMS).

    Journal of applied physics·2014
    Same author

    Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans.

    Clinical oral investigations·2004
    Same author

    [Mycotic aneurysms--A retrospective analysis].

    Zentralblatt fur Chirurgie·2002
    Same author

    Jürgen Drews discusses the future of the industry. Interviewed by Rebecca N. Lawrence.

    Drug discovery today·2001
    Same author

    Quo vadis, biotech? (Part 2).

    Drug discovery today·2001
    Same author

    Drug discovery: a historical perspective.

    Science (New York, N.Y.)·2000

    Area of Science:

    • Immunopharmacology
    • Microbiology
    • Biochemistry

    Background:

    • Immunostimulating drugs aim to enhance the immune system's response.
    • Microbial agents, synthetic compounds, and lymphokines represent distinct classes of immunostimulators.
    • Challenges in standardization and dosage have impacted the clinical efficacy of some immunostimulants.

    Purpose of the Study:

    • To review different classes of immunostimulating drugs.
    • To discuss the rationale, clinical applications, and limitations of various immunostimulatory approaches.
    • To highlight emerging areas in immunopharmacology.

    Main Methods:

    • Literature review of immunostimulating drug classes.
    • Discussion of microbial agents (e.g., BCG), synthetic compounds (e.g., Levamisole), and lymphokines.

    Related Experiment Videos

  • Analysis of clinical outcomes and future research directions.

    • Main Results:

    • Microbial agents show potential, with exceptions like BCG in melanoma and bladder carcinoma treatment.
    • Synthetic compounds like Levamisole have specific, limited applications.
    • Purine-containing compounds are significant due to their role in immune deficiencies.
    • Lymphokines are emerging as valuable tools for studying immune function.

    Conclusions:

    • Immunostimulation encompasses diverse pharmacological strategies.
    • Further research and standardization are needed for optimal therapeutic use of immunostimulants.
    • Lymphokines represent a promising frontier in immunopharmacology and immune function research.